Charles Kummeth
2019
In 2019, Charles Kummeth earned a total compensation of $11M as President and CEO at Bio-Techne, a 14% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $2,008,183 |
|---|---|
| Option Awards | $4,000,343 |
| Salary | $957,000 |
| Stock Awards | $3,999,925 |
| Other | $45,688 |
| Total | $11,011,138 |
Kummeth received $4M in option awards, accounting for 36% of the total pay in 2019.
Kummeth also received $2M in non-equity incentive plan, $957K in salary, $4M in stock awards and $45.7K in other compensation.
Rankings
In 2019, Charles Kummeth's compensation ranked 632nd out of 13,971 executives tracked by ExecPay. In other words, Kummeth earned more than 95.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 632 out of 13,971 | 96th |
Division Manufacturing | 225 out of 5,701 | 96th |
Major group Chemicals And Allied Products | 58 out of 2,200 | 97th |
Industry group Drugs | 48 out of 1,886 | 98th |
Industry Biological Products, Except Diagnostic Substances | 9 out of 389 | 98th |
Source: SEC filing on September 9, 2019.
Kummeth's colleagues
We found four more compensation records of executives who worked with Charles Kummeth at Bio-Techne in 2019.